4//SEC Filing
LEWIS JOSEPH 4
Accession 0000895345-23-000524
CIK 0001808865other
Filed
Aug 24, 8:00 PM ET
Accepted
Aug 25, 9:28 PM ET
Size
13.8 KB
Accession
0000895345-23-000524
Insider Transaction Report
Form 4
Boxer Capital, LLC
10% Owner
Transactions
- Sale
Common Stock
2023-08-23$14.19/sh−34,846$494,465→ 2,119,212 total - Sale
Common Stock
2023-08-23$15.63/sh−95,516$1,492,915→ 2,023,696 total - Sale
Common Stock
2023-08-23$16.87/sh−219,638$3,705,293→ 1,804,058 total
LEWIS JOSEPH
10% Owner
Transactions
- Sale
Common Stock
2023-08-23$16.87/sh−219,638$3,705,293→ 1,804,058 total - Sale
Common Stock
2023-08-23$14.19/sh−34,846$494,465→ 2,119,212 total - Sale
Common Stock
2023-08-23$15.63/sh−95,516$1,492,915→ 2,023,696 total
Davis Aaron I.
Director10% Owner
Transactions
- Sale
Common Stock
2023-08-23$16.87/sh−219,638$3,705,293→ 1,804,058 total - Sale
Common Stock
2023-08-23$14.19/sh−34,846$494,465→ 2,119,212 total - Sale
Common Stock
2023-08-23$15.63/sh−95,516$1,492,915→ 2,023,696 total
Boxer Asset Management Inc.
10% Owner
Transactions
- Sale
Common Stock
2023-08-23$14.19/sh−34,846$494,465→ 2,119,212 total - Sale
Common Stock
2023-08-23$15.63/sh−95,516$1,492,915→ 2,023,696 total - Sale
Common Stock
2023-08-23$16.87/sh−219,638$3,705,293→ 1,804,058 total
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.80 to $14.59, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]These securities are owned directly by Boxer Capital, LLC ("Boxer Capital"). Boxer Asset Management Inc. is the managing member of Boxer Capital. Joseph Lewis is the sole indirect owner of Boxer Asset Management Inc. Mr. Davis is a member of Boxer Capital. Each reporting person other than Boxer Capital disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any.
- [F3]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.05 to $15.85, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $16.50 to $17.04, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Documents
Issuer
iTeos Therapeutics, Inc.
CIK 0001808865
Entity typeother
Related Parties
1- filerCIK 0001015747
Filing Metadata
- Form type
- 4
- Filed
- Aug 24, 8:00 PM ET
- Accepted
- Aug 25, 9:28 PM ET
- Size
- 13.8 KB